Ledger.Open graph →

SEC Form D · Amendment · filed January 15, 2015

XRpro Sciences, Inc

Offering

$8.9M

Sold

$8.9M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Richard Cunningham · Cambridge, MAExec Clive Kabatznik · Cambridge, MADirector Benjamin Warner · Cambridge, MAExec · Director Edward Roffman · Cambridge, MADirector Vincent Palmieri · Cambridge, MADirector Timothy Tyson · Cambridge, MADirector Mark Korb · Cambridge, MAExec Michael Taglich · Cambridge, MADirector Michael R. Graham · Calgary, Alberta, CanadaDirector Mark Neveu · Waltham, MAExec Jeff Knupp · Chicago, ILDirector William A. Starkey · The Woodlands, TXExec Stuart Rose · Albuquerque, NMDirector Brian Newman · Chicago, ILDirector True North Ventures, LLC · Flagstaff, AZDirector Jim W. Riddell · Calgary, Alberta, CanadaDirector M. D. Young · McLean, VAExec David M. Nicklas · Pittsburgh, PAExec · Director Vista Energy Resources, Inc · Pittsburgh, PADirector Clark R. Nicklas · Pittsburgh, PAExec · Director Mark Vipond · Omaha, NEExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗